{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"24ee0efe4bbb","filters":{"venue":"International Journal of Hematologic Oncology"}},"results":[{"id":"W2191286751","doi":"10.2217/ijh.15.22","title":"Update on Recurrent Genetic Aberrations in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"International Journal of Hematologic Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Myeloid leukemia; Medicine; Karyotype; Risk stratification; Oncology; Internal medicine; Bioinformatics; Gene; Chromosome; Genetics; Biology","authors":[{"name":"Kareem Jamani","is_ca":true},{"name":"Carolyn Owen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04949742693997719,"gpt":0.3901499777116815,"spread":0.3406525507717043,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001382485,0.000639746,0.001415683,0.002933,0.0003036981,0.001148156,0.0009140862,0.001245126,0.003423358],"category_scores_gemma":[0.003454428,0.0002960604,0.0006751698,0.002529007,0.0004253496,0.001738968,0.0007332999,0.002361218,0.001716933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007098226,"about_ca_system_score_gemma":0.001120359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275568,"about_ca_topic_score_gemma":0.003449815,"domain_scores_codex":[0.999487,0.0001071857,0.0001221509,0.00006698498,0.0001789357,0.00003770594],"domain_scores_gemma":[0.9970167,0.001431908,0.0003084449,0.00006597725,0.0009391008,0.0002380014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001306551,0.00005282641,0.001053098,0.00725234,0.0001542055,0.0008959249,0.00009663534,0.000299797,0.001414467,0.001387686,0.2170701,0.7701923],"study_design_scores_gemma":[0.00001512388,0.00008751997,0.001769664,0.003485206,0.0002608808,0.003159306,0.00005993383,0.0000935354,0.0003104093,0.000726213,0.9900097,0.00002239192],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005370506,0.9864611,0.0005941914,0.004681205,0.005228266,0.00001335947,0.0001587249,0.00005268606,0.002273344],"genre_scores_gemma":[0.002146384,0.980989,0.001200553,0.004284912,0.009218711,0.00001836076,0.0003853814,0.00001496142,0.001741709],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003423358,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077076503","doi":"10.2217/ijh.14.35","title":"Ruxolitinib for the Treatment of Disease-Related Splenomegaly or Symptoms in Adult Patients with Myelofibrosis","year":2014,"lang":"en","type":"article","venue":"International Journal of Hematologic Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Alberta","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Constitutional symptoms; Myeloproliferative neoplasm; Anemia; Natural history; Disease; Internal medicine; Pediatrics; Intensive care medicine; Bone marrow","authors":[{"name":"Elena Liew","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01445894224092989,"gpt":0.3111262826682992,"spread":0.2966673404273693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002478966,0.0001431057,0.0003506205,0.0001752041,0.0001982955,0.0001883282,0.0001063125,0.0002863134,0.000763913],"category_scores_gemma":[0.0003282167,0.00004720348,0.0001688204,0.0001325847,0.00009730979,0.0001430836,0.0001181728,0.0004946754,0.0002185554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001523391,"about_ca_system_score_gemma":0.000227798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002258778,"about_ca_topic_score_gemma":0.0007874141,"domain_scores_codex":[0.9999399,0.0000197001,0.00001010434,0.00000519997,0.000009330171,0.00001576789],"domain_scores_gemma":[0.9998692,0.00003417308,0.00003390883,0.000003734497,0.00001243061,0.0000466182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.009850192,0.001147024,0.1529994,0.001422569,0.0003423302,0.03325156,0.0004291748,0.001291691,0.02749965,0.001890099,0.03549124,0.7343851],"study_design_scores_gemma":[0.00707057,0.02644415,0.4628762,0.002076285,0.001162042,0.2376241,0.0006413584,0.008264028,0.02415035,0.002803818,0.2267732,0.0001138149],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8623973,0.1137163,0.001469525,0.005524744,0.00034113,0.0001717176,0.0003791312,0.0001422688,0.01585803],"genre_scores_gemma":[0.9857453,0.01062487,0.001058033,0.001134743,0.0002683136,0.00004174162,0.0002522937,0.000003940488,0.0008706972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000763913,"threshold_uncertainty_score":0.002555549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2576428875","doi":"10.2217/ijh-2016-0014","title":"Management of Multiple Myeloma: The Impact of Ixazomib’s Approval in Canada","year":2016,"lang":"en","type":"article","venue":"International Journal of Hematologic Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; University of Kentucky; International Myeloma Foundation","keywords":"Medicine; Family medicine; Internship; Internal medicine; Medical education","authors":[{"name":"Donna Reece","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02964974679434092,"gpt":0.3644268375009572,"spread":0.3347770907066163,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005535044,0.0003164402,0.0007713689,0.001505683,0.00294255,0.00567853,0.002255216,0.003222793,0.01018241],"category_scores_gemma":[0.02312156,0.000366068,0.0008559456,0.003453633,0.002182952,0.001777785,0.001631453,0.00464996,0.0005820922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06123996,"about_ca_system_score_gemma":0.1580314,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8649526,"about_ca_topic_score_gemma":0.9323918,"domain_scores_codex":[0.9924657,0.0009495571,0.0005697231,0.0005618364,0.003871364,0.001581799],"domain_scores_gemma":[0.952502,0.005269036,0.003619073,0.0006336912,0.02102397,0.01695224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002430726,0.0003781557,0.07748932,0.001580693,0.000358381,0.003238936,0.0009670373,0.002357061,0.001298564,0.03033864,0.3679709,0.5115916],"study_design_scores_gemma":[0.001175789,0.0005183412,0.1694854,0.005653594,0.0002848909,0.002394242,0.001791527,0.001546518,0.0005215979,0.003191102,0.8132775,0.0001593736],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.05820629,0.1543888,0.000966115,0.6691051,0.007887138,0.0002239598,0.002392199,0.0001099383,0.1067206],"genre_scores_gemma":[0.6136066,0.182598,0.005062983,0.1605954,0.00639579,0.0001789547,0.003933551,0.0004010626,0.02722766],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1350474,"threshold_uncertainty_score":0.4443291,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}